11.65 USD
+0.06 (+0.52%)
11.5516 USD
-0.1 (-0.84%)
VTRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of VTRS while its profitability can be described as average. VTRS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year VTRS was profitable.
VTRS had a positive operating cash flow in the past year.
In multiple years VTRS reported negative net income over the last 5 years.
VTRS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of VTRS (-9.73%) is better than 67.02% of its industry peers.
With a decent Return On Equity value of -24.26%, VTRS is doing good in the industry, outperforming 63.87% of the companies in the same industry.
VTRS's Return On Invested Capital of 3.41% is amongst the best of the industry. VTRS outperforms 80.63% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VTRS is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROIC | 3.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
1.3 Margins
The Operating Margin of VTRS (9.34%) is better than 82.20% of its industry peers.
In the last couple of years the Operating Margin of VTRS has declined.
VTRS has a better Gross Margin (39.36%) than 60.73% of its industry peers.
In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% |
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VTRS is destroying value.
VTRS has less shares outstanding than it did 1 year ago.
VTRS has more shares outstanding than it did 5 years ago.
VTRS has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.92, we must say that VTRS is in the distress zone and has some risk of bankruptcy.
VTRS has a Altman-Z score (0.92) which is in line with its industry peers.
The Debt to FCF ratio of VTRS is 8.96, which is on the high side as it means it would take VTRS, 8.96 years of fcf income to pay off all of its debts.
VTRS has a Debt to FCF ratio of 8.96. This is in the better half of the industry: VTRS outperforms 79.58% of its industry peers.
VTRS has a Debt/Equity ratio of 0.82. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
The Debt to Equity ratio of VTRS (0.82) is worse than 71.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Altman-Z | 0.92 |
ROIC/WACC0.43
WACC7.88%
2.3 Liquidity
A Current Ratio of 1.35 indicates that VTRS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.35, VTRS is doing worse than 73.30% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that VTRS may have some problems paying its short term obligations.
VTRS has a worse Quick ratio (0.79) than 82.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The earnings per share for VTRS have decreased strongly by -14.65% in the last year.
VTRS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.73% yearly.
The Revenue has decreased by -6.14% in the past year.
VTRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
3.2 Future
VTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.45% yearly.
Based on estimates for the next years, VTRS will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.00, the valuation of VTRS can be described as very cheap.
VTRS's Price/Earnings ratio is rather cheap when compared to the industry. VTRS is cheaper than 96.86% of the companies in the same industry.
VTRS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
VTRS is valuated cheaply with a Price/Forward Earnings ratio of 4.62.
Based on the Price/Forward Earnings ratio, VTRS is valued cheaper than 96.34% of the companies in the same industry.
VTRS is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5 | ||
| Fwd PE | 4.62 |
4.2 Price Multiples
95.29% of the companies in the same industry are more expensive than VTRS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VTRS is valued cheaper than 92.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.33 | ||
| EV/EBITDA | 6.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
5. Dividend
5.1 Amount
VTRS has a Yearly Dividend Yield of 4.46%, which is a nice return.
VTRS's Dividend Yield is rather good when compared to the industry average which is at 5.65. VTRS pays more dividend than 96.34% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, VTRS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
5.2 History
VTRS has paid a dividend for at least 10 years, which is a reliable track record.
VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
VTRS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.34%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
11.65
+0.06 (+0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners86.85%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change-0.14%
Market Cap13.42B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts71.76
Price Target12.38 (6.27%)
Short Float %2.04%
Short Ratio2.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.46% |
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)3.36%
PT rev (3m)10%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)-1.94%
EPS NY rev (1m)1.34%
EPS NY rev (3m)1.51%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)2.3%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)1.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5 | ||
| Fwd PE | 4.62 | ||
| P/S | 0.95 | ||
| P/FCF | 8.33 | ||
| P/OCF | 6.77 | ||
| P/B | 0.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.49 |
EPS(TTM)2.33
EY20%
EPS(NY)2.52
Fwd EY21.65%
FCF(TTM)1.4
FCFY12.01%
OCF(TTM)1.72
OCFY14.78%
SpS12.26
BVpS13.21
TBVpS-6.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number26.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| ROCE | 4.32% | ||
| ROIC | 3.41% | ||
| ROICexc | 3.53% | ||
| ROICexgc | 14.83% | ||
| OM | 9.34% | ||
| PM (TTM) | N/A | ||
| GM | 39.36% | ||
| FCFM | 11.41% |
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)4.05%
ROIC(5y)3.56%
ROICexc(3y)4.16%
ROICexc(5y)3.64%
ROICexgc(3y)17.86%
ROICexgc(5y)17.54%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 8.96 | ||
| Debt/EBITDA | 3.05 | ||
| Cap/Depr | 13.37% | ||
| Cap/Sales | 2.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.4% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 0.92 |
F-Score4
WACC7.88%
ROIC/WACC0.43
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.83%
EPS Next 2Y-2.45%
EPS Next 3Y1.45%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.59%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-5.05%
EBIT Next 3Y0.82%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%
VIATRIS INC / VTRS FAQ
What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to VTRS.
Can you provide the valuation status for VIATRIS INC?
ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.
What is the profitability of VTRS stock?
VIATRIS INC (VTRS) has a profitability rating of 5 / 10.
Can you provide the financial health for VTRS stock?
The financial health rating of VIATRIS INC (VTRS) is 3 / 10.
Can you provide the expected EPS growth for VTRS stock?
The Earnings per Share (EPS) of VIATRIS INC (VTRS) is expected to decline by -10.83% in the next year.